In this single-cohort pilot study the combined role of the biomarkers HMGA2, PPARG, ADIPOQ and IL6 as predictors for T2D remission after metabolic surgery were evaluated. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.